DENVER , March 28, 2022 /PRNewswire/ – Schwazze, (OTCQX:SHWZ) (NEO:SHWZ) (“Schwazze” or the “Company”), announces that it will host a year-end conference call and webcast for the fourth quarter of 2021 on March 31, 2022 at 4:30 p.m. ET.

Investors and stakeholders may participate in the conference call by dialing 416 764 8650 or by dialing the North American toll-free number 888-664-6383 or by listening to the webcast from the Company’s website at address The webcast will be available on the Company’s website and for replay until April 7, 2022and can be viewed by dialing 888-390-0541 / 040354#.

Following their prepared remarks, Mr. Director General, Justin Dye and Chief Financial Officer, Nancy Huber will answer questions from investors. Investors can submit questions in advance or during the conference call itself via the web link: This web link was posted on the Company’s website and will be archived on the website. All of the Company’s SEC filings are also available on the Company’s website at

About Schwazze

Schwazze (OTCQX:SHWZ) is building a first vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to expand its operating system to other states where it can develop a position of differentiated regional leadership. Schwazze is the parent company to a portfolio of leading cannabis businesses and brands from seed to retail. The company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is rooted in a high performance culture that combines customer-centric thinking and data science to test, measure and drive decisions and results. The company’s management team has deep expertise in retail, wholesale and building consumer brands in Fortune 500 companies as well as the cannabis industry. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices. Medicine Man Technologies, Inc. was the former trading name of Schwazze. The corporate entity continues to be called Medicine Man Technologies, Inc. Schwazze derives its name from the technique of pruning a cannabis plant to improve plant structure and promote healthy growth.

Forward-Looking Statements – We need to update based on our new listing

This press release contains “forward-looking statements”. These statements may be preceded by the words “may”, “believes”, “predicts” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of the Company and cannot be predicted or quantified. Therefore, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale by ourselves or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competitors; (iv) the loss of one or more key executives or scientists; (v) difficulties obtaining regulatory approval to commercialize our products and product candidates; (vi) our ability to successfully execute our growth strategy by Colorado and out of state, (vii) our ability to identify and complete future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) actual revenue from the Company’s Star Buds assets,* the Company’s actual revenue and Adjusted EBITDA for 2021, (xi) the Company’s ability to generate positive cash flow for the remainder of 2021 (xii) the ongoing COVID-19 pandemic, (xiii) the timing and extent of government stimulus programs, and (xiv) uncertainty in the application of federal, state and local laws to our business, and any changes to these laws. More detailed information about the company and the risk factors that may affect the making of forward-looking statements is set forth in the company’s filings with the Securities and Exchange Commission (SEC), including the company’s annual report on Form 10. -K and its Quarterly Report Reports on Form 10-Q. Investors and security holders are urged to read these materials free of charge on the SEC’s website at The Company undertakes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise, except as required by law.

View original content to download multimedia:–webcast-march-31-2022-301511441. html

SOURCEMedicine Man Technologies, Inc.

Michael P. Boser